Concorde Asset Management’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-67,772
Closed -$2.71M 86
2022
Q4
$2.71M Buy
67,772
+36,120
+114% +$1.42M 2.41% 6
2022
Q3
$1.12M Buy
+31,652
New +$1.27M 1.26% 16
2022
Q2
Sell
-74,623
Closed -$3.15M 119
2022
Q1
$3.15M Buy
74,623
+17,304
+30% +$737K 2.09% 10
2021
Q4
$2.14M Buy
57,319
+36,059
+170% +$1.28M 1.28% 15
2021
Q3
$750K Sell
21,260
-50,431
-70% -$1.89M 0.43% 84
2021
Q2
$2.82M Buy
71,691
+35,512
+98% +$1.39M 1.58% 14
2021
Q1
$1.4M Buy
+36,179
New +$1.36M 0.81% 37

Other funds holding BTI

Concorde Asset Management's BTI Position: Q1 2023 in Review

Concorde Asset Management sold out of British American Tobacco (BTI) in Q1 2023, closing a stake of 67,772 shares — an estimated $2.71M sold.

Concorde Asset Management first reported a position in BTI in Q1 2021 and held it in 7 quarters. The position peaked at $3.15M in Q1 2022. 572 funds tracked by Wall St. Rank hold BTI as of Q1 2023.

  • Concorde Asset Management reported no remaining British American Tobacco position as of Q1 2023 after selling out during the quarter.
  • Concorde Asset Management sold 67,772 British American Tobacco shares in Q1 2023, an estimated $2.71M.
  • Concorde Asset Management first reported a position in British American Tobacco in Q1 2021 and held it in 7 quarters.
  • Concorde Asset Management's British American Tobacco position peaked at $3.15M in Q1 2022.
  • 572 funds tracked by Wall St. Rank held British American Tobacco as of Q1 2023.

Based on Concorde Asset Management's 13F filing for Q1 2023, filed 9 May 2023.